{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:13:58Z","timestamp":1789686838888,"version":"4.0.1"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Centrosomal Protein 55 (CEP55) was initially described as a main participant in the final stage of cytokinesis. Further research identified CEP55 as a cancer-testis antigen (CTA) that is aberrantly expressed in different malignancies and a cancer vaccination candidate. The current study aimed to disclose the complete expression of CEP55, its effect on various malignancy prognoses, and its role in the tumor microenvironment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Transcriptional information regarding tumor and normal tissues, as well as externally validated and protein expression data were gathered from the Cancer Genome Atlas, Genotype-Tissue Expression project, Gene Expression Omnibus, and Human Protein Atlas. We examined the effect of CEP55 on tumor prognosis using Kaplan-Meier (KM) and univariate Cox regression analyses. In addition, we investigated the connections between CEP55 expression and hallmark cancer pathways, immune cell infiltration, and immune regulator expression across malignancies. We constructed and validated a CEP55-related risk model for hepatocellular carcinoma (HCC) and explored the correlations between CEP55 expression and HCC molecular subtypes. Finally, we investigated putative small-molecule drugs targeting CEP55 using a connectivity map (CMap) database and validated them using molecular docking analysis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Findings:<\/jats:bold>\n                    CEP55 was aberrantly expressed in most cancers and revealed a prognostic value for several malignancies. Cancers with high CEP55 expression showed significantly enhanced cell cycle, proliferation, and immune-related pathways. For most malignancies, elevated CEP55 expression was associated with the infiltration of myeloid-derived suppressor cells (MDSCs) and Th2 cells. In addition, CEP55 expression was linked to immunomodulators and the potential prediction of immune checkpoint inhibitor (ICI) responses, and strongly associated with distinct molecular HCC subtypes, whereby the CEP55-based nomogram performed well in predicting short- and long-term HCC survival. Finally, we used connectivity map (CMap) and molecular docking analyses to discover three candidate small-molecule drugs that could directly bind to CEP55.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    CEP55 affected the occurrence and development of various cancers and possibly the regulation of the tumor immune microenvironment. Our findings suggest that CEP55 is a potential biomarker for prognosis and a powerful biomarker for ICI efficacy prediction.\n                  <\/jats:p>","DOI":"10.3389\/fmolb.2023.1198557","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T07:55:55Z","timestamp":1688716555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Xiaodong","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wushuang","family":"Jiangting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhulin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"a028480","DOI":"10.1101\/cshperspect.a028480","article-title":"Interferon \u0393 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity","volume":"11","author":"Alspach","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"669474","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and regulation of T(H) cells: A balancing act for cancer immunotherapy","volume":"12","author":"Basu","year":"2021","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-genet-021920-092410","article-title":"Rad51 gene family structure and function","volume":"54","author":"Bonilla","year":"2020","journal-title":"Annu. Rev. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of hcc is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatol. Baltim. Md)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng1861","article-title":"A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers","volume":"38","author":"Carter","year":"2006","journal-title":"Nat. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.Cd-12-0095","article-title":"The cbio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/ijms22010073","article-title":"The many faces of Cd4(+) T cells: Immunological and structural characteristics","volume":"22","author":"Chatzileontiadou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1038\/onc.2009.128","article-title":"Expression of Flj10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased Foxm1 and mmp-2 activity","volume":"28","author":"Chen","year":"2009","journal-title":"Oncogene"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1038\/sj.onc.1210207","article-title":"Flj10540-Elicited cell transformation is through the activation of pi3-kinase\/akt pathway","volume":"26","author":"Chen","year":"2007","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s12094-018-02012-8","article-title":"Cep55 promotes epithelial-mesenchymal transition in renal cell carcinoma through pi3k\/akt\/mtor pathway","volume":"21","author":"Chen","year":"2019","journal-title":"Clin. Transl. Oncol. official Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mexico"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/onc.2015.186","article-title":"Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic kras and braf","volume":"35","author":"Cisowski","year":"2016","journal-title":"Oncogene"},{"key":"B12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1083\/jcb.65.2.271","article-title":"Response of myogenic and fibrogenic cells to cytochalasin B and to colcemid. I. Light microscope observations","volume":"65","author":"Croop","year":"1975","journal-title":"J. Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.devcel.2005.09.003","article-title":"Cdk1\/Erk2-and plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis","volume":"9","author":"Fabbro","year":"2005","journal-title":"Dev. Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"eabc1495","DOI":"10.1126\/science.abc1495","article-title":"Cdk4 and Cdk6 kinases: From basic science to cancer therapy","volume":"375","author":"Fassl","year":"2022","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0233283","DOI":"10.1371\/journal.pone.0233283","article-title":"The value of Cep55 gene as a diagnostic biomarker and independent prognostic factor in luad and lusc","volume":"15","author":"Fu","year":"2020","journal-title":"PloS one"},{"key":"B16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cbioportal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"B18","first-page":"1456","article-title":"An adoptive T cell immunotherapy targeting cancer stem cells in a colon cancer model","volume":"20","author":"Gao","year":"2015","journal-title":"J. BUON official J. Balkan Union Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1158\/0008-5472.Can-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.it.2016.04.010","article-title":"Targeted therapy and checkpoint immunotherapy combinations for the treatment of cancer","volume":"37","author":"Hughes","year":"2016","journal-title":"Trends Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/CJI.0b013e3181a1d109","article-title":"Cep55\/C10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma","volume":"32","author":"Inoda","year":"2009","journal-title":"J. Immunother. Hagerst. Md 1997"},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yexmp.2010.10.001","article-title":"The feasibility of Cep55\/C10orf3 derived peptide vaccine therapy for colorectal carcinoma","volume":"90","author":"Inoda","year":"2011","journal-title":"Exp. Mol. pathology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/onc.2015.128","article-title":"Beyond cytokinesis: The emerging roles of Cep55 in tumorigenesis","volume":"35","author":"Jeffery","year":"2016","journal-title":"Oncogene"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1158\/1078-0432.Ccr-04-2225","article-title":"Gene signatures of progression and metastasis in renal cell cancer","volume":"11","author":"Jones","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"B25","first-page":"223","article-title":"Th1\/Th2 balance: The hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern. Med. Rev. a J. Clin. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1573406417666201204161243","article-title":"Synthesis and clinical development of palbociclib: An overview","volume":"18","author":"Konar","year":"2022","journal-title":"Med. Chem. (Shariqah (United Arab. Emir."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Sci. (New York, NY)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.20375","article-title":"Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatol. Baltim. Md)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41568-018-0084-6","article-title":"Cytokinesis defects and cancer","volume":"19","author":"Lens","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/cells7080099","article-title":"Cep55 promotes cell motility via Jak2\u207bStat3\u207bMmps cascade in hepatocellular carcinoma","volume":"7","author":"Li","year":"2018","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.Can-17-0307","article-title":"Timer: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"Timer2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","article-title":"Gene expression profiles of human breast cancer progression","volume":"100","author":"Ma","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/sj.onc.1210792","article-title":"Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information","volume":"27","author":"Montero-Conde","year":"2008","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.18.1.451","article-title":"Signaling and transcription in T helper development","volume":"18","author":"Murphy","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 cells in health and disease","volume":"35","author":"Nakayama","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e154402","DOI":"10.1172\/jci.insight.154402","article-title":"Rb expression confers sensitivity to cdk4\/6 inhibitor-mediated radiosensitization across breast cancer subtypes","volume":"7","author":"Pesch","year":"2022","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4161\/onci.1.1.17939","article-title":"Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer","volume":"1","author":"Protti","year":"2012","journal-title":"Oncoimmunology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-018-0846-5","article-title":"Transcriptome reprogramming by cancer exosomes: Identification of novel molecular targets in matrix and immune modulation","volume":"17","author":"Qadir","year":"2018","journal-title":"Mol. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for rna-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","article-title":"In vivo CD4+ T cell differentiation and function: Revisiting the Th1\/Th2 paradigm","volume":"38","author":"Ruterbusch","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/sj.onc.1209051","article-title":"Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor","volume":"25","author":"Sakai","year":"2006","journal-title":"Oncogene"},{"key":"B45","doi-asserted-by":"publisher","first-page":"W48","DOI":"10.1093\/nar\/gkaa235","article-title":"Proteinsplus: Interactive analysis of protein-ligand binding interfaces","volume":"48","author":"Sch\u00f6ning-Stierand","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"B48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1007\/s13277-013-1578-1","article-title":"Cep55 contributes to human gastric carcinoma by regulating cell proliferation","volume":"35","author":"Tao","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Sci. (New York, NY)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"D485","DOI":"10.1093\/nar\/gku1007","article-title":"Comppi: A cellular compartment-specific database for protein-protein interaction network analysis","volume":"43","author":"Veres","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1573406415666190416120801","article-title":"Recent advances in therapeutic applications of bisbenzimidazoles","volume":"16","author":"Verma","year":"2020","journal-title":"Med. Chem. (Shariqah (United Arab. Emir."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.Cd-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"B57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-017-0467-2","article-title":"Recent advances of highly selective cdk4\/6 inhibitors in breast cancer","volume":"10","author":"Xu","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"8890715","DOI":"10.1155\/2021\/8890715","article-title":"Cep55 positively affects tumorigenesis of esophageal squamous cell carcinoma and is correlated with poor prognosis","volume":"2021","author":"Yan","year":"2021","journal-title":"J. Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"4139320","DOI":"10.1155\/2020\/4139320","article-title":"Upregulation of Cep55 predicts dismal prognosis in patients with liver cancer","volume":"2020","author":"Yang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-018-0872-3","article-title":"Spag5 interacts with Cep55 and exerts oncogenic activities via pi3k\/akt pathway in hepatocellular carcinoma","volume":"17","author":"Yang","year":"2018","journal-title":"Mol. Cancer"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics a J. Integr. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1091\/mbc.e06-01-0015","article-title":"Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis","volume":"17","author":"Zhao","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.3390\/ijms21218011","article-title":"Cd4 T helper cell subsets and related human immunological disorders","volume":"21","author":"Zhu","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1198557\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T07:56:01Z","timestamp":1688716561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1198557\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":64,"alternative-id":["10.3389\/fmolb.2023.1198557"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1198557","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"article-number":"1198557"}}